Quick-Med Technologies and Avery Dennison have entered into a joint development and exclusive option agreement to collaborate in applying Quick-Med's Nimbus technology to adhesives for medical device and industrial applications.
Subscribe to our email newsletter
According to Quick-Med Technologies, Nimbus is a next-generation antimicrobial technology that is non-leaching, non-toxic, long-lasting and not blocked by organics such as blood, urine and perspiration.
Ladd Greeno, CEO of Quick-Med Technologies, said: “We are excited to team with Avery Dennison to incorporate our advanced Nimbus technology in adhesives. This collaboration will leverage Nimbus technology to a next generation of antimicrobial adhesives to address growing infection concerns.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.